Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology

Immune-related adverse events on 18F-FDG PET/CT in patients undergoing immune checkpoint inhibitor therapy

Ashwin Singh Parihar and Richard Wahl
Journal of Nuclear Medicine June 2022, 63 (supplement 2) 2720;
Ashwin Singh Parihar
1Mallinckrodt Institute of Radiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Wahl
1Mallinckrodt Institute of Radiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 63 no. supplement 2 2720

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 8, 2022.

Copyright & Usage 
© 2022

Author Information

  1. Ashwin Singh Parihar and
  2. Richard Wahl
  1. 1Mallinckrodt Institute of Radiology

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: August 2022 to February 2023

AbstractFullPdf
Aug 20221400
Sep 20222100
Oct 20221300
Nov 20221700
Dec 20221900
Jan 20233000
Feb 20231400
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
June 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Immune-related adverse events on 18F-FDG PET/CT in patients undergoing immune checkpoint inhibitor therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Immune-related adverse events on 18F-FDG PET/CT in patients undergoing immune checkpoint inhibitor therapy
Ashwin Singh Parihar, Richard Wahl
Journal of Nuclear Medicine Jun 2022, 63 (supplement 2) 2720;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Immune-related adverse events on 18F-FDG PET/CT in patients undergoing immune checkpoint inhibitor therapy
Ashwin Singh Parihar, Richard Wahl
Journal of Nuclear Medicine Jun 2022, 63 (supplement 2) 2720;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Considerations and approach prior to treatment with 177Lutetium DOTATATE Radionuclide Therapy
  • Expanding Role of Positron Emission Tomography in Management of Prostate Cancer: Current Status and Future Directions
  • A Sheep in Wolf’s Clothing: Beware of Physiologic Ureteric Activity Mimicking a Pathologic Lymph Node!
Show more Oncology

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire